Michael Bradaric, PhD
Hillary Kenny, PhD
Andras Landanyi, MD
Anirban Kumar Mitra PhD
Kelsey Angell McEwen Kristin Nieman, PhD
Anna McCormick
Carla Penicka
Iris Romero, MD
Payal Tiwari, BA
Yilin Zhang
Marion Zilhardt, MS
Geri Cooper
Lab Members
Michael Bradaric, PhD
|
Mike recently completed his PhD from Rush University, Chicago, Illinois in the Department of Pharmacology. There, he studied the immunological components of ovarian cancer in the hen, another model used to study ovarian cancer which spontaneously arises in these animals. He is working as a post-doctoral scholar with Dr. Romero studying the effects of novel pharmacologic agents to help in the treatment and prevention of ovarian cancer. |
Hillary Kenny, PhD
|
Hilary A. Kenny is a Research Associate (Assistant Professor) in the Department of OBGYN. Her research focus is on the role of the microenvironment during early ovarian cancer metastasis. In particular, she has been investigating the role of integrins, proteases and the extra-cellular matrix in the immediate early response of ovarian cancer cells to the omental microenvironment (main site of ovarian cancer metastasis). |
Anirban Kumar Mitra, PhD
Postdoctoral Fellow |
Anirban Kumar Mitra received his masters in Biotechnology from Devi Ahilya University, Indore, India and his Ph.D. from Mumbai University, Mumbai, India. While working in the Lengyel Laboratory,he developed a keen interest in ovarian cancer biology. He is now exploring the role of the microenvironment in ovarian cancer progression with a focus on carcinoma associated fibroblasts. He is also interested in the function of alpha5 beta1-integrin in ovarian cancer metastasis |
Andras Ladanyi, MD Gynecologic Oncology Fellow |
Dr. Ladanyi is a Fellow in the Gynecologic Oncology Section, Department of OBGYN at the University of Chicago |
Kristin Nieman, PhD
|
Kristin Nieman received her B.A. fromWartburg College, Waverly, IA and her M.S. and Ph.D from Iowa State University, Ames, IA Her research focuses on determining if adipocytes, the primary cell type in the omentum, play a role in ovarian cancer metastasis to the omentum. If a role for adipocytes is established it could lead to the development of novel targets, which are desperately needed, for the treatment of ovarian cancer |
Carla Penicka, BA
|
Carla Penicka graduated from the University of Chicago in 2010, double majoring in chemistry and biological sciences. She is currently applying to medical school. |
Iris Romero, MD |
Dr. Iris Romero is an Assistant Professor in the department of Ob/Gyn with a research emphasis in ovarian cancer prevention. Drs. Romero and Lengyel have long-standing collaboration which fuses Dr. Romero’s background in family planning and Dr. Lengyel’s background in gynecological oncology in hopes of identifying novel molecularly targeted prevention strategies for women at high risk for ovarian cancer. |
Payal Tiwari, MS |
Payal Tiwara is from Sonipat, Haryana, India.She received her masters from IIT Chicago.She to learn different new techniques, to develop a scientific rationale to use them and also getting ready to take responsibilities for PhD.” |
Yilin Zhang, PhD
|
Yilin Zhang received his B.A from Hunan Normal University, M.S from Wuhan University, and Ph.D from University of Southern Mississippi in major of Biochemistry. His work focuses on ligands-directed delivery of therapeutic/diagnostic, nano-scale molecules (i.e, nanomedicine) into tumors via the mediation of receptors which specifically over-express in human ovarian cancer cells. The novel nanomedicines not only reduce the side effects of their cargoes (e.g. cisplastin), but enhance the cellular uptake, and therefore will ultimately improve the outcome of therapeutics and/or diagnostics. |
Marion Zilhardt, PhD |
MarionZilhardt grew up in Minnesota where she stayed for her undergraduate degree at Hamline University, where she majored in biology. After two years working as a technician at the University of Minnesota, she joined the University of Chicago as a PhD student in the Committee on Cancer Biology. Currently her work centers around the role of a receptor tyrosine kinase, c-Met, in ovarian cancer and how crosstalk with the tumor microenvironment affects activation of this signaling pathway. |
Geri Cooper
|
|
Kelsey Angell McEwen
|
|
